Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
    • Subscribe
Advertisement

Article

March 8, 2021

Death From Heart-Related Causes May Affect Cancer Survivors More Than the General Population

Author(s):

Darlene Dobkowski, MA

More than half of the deaths assessed in this study were related to non-cancer-related causes such as cardiovascular disease compared with cancer-related causes, which may reflect a need for risk factor management for heart disease during survivorship.

Patients who were alive five years after receiving a cancer diagnosis were more likely to die from cardiovascular disease compared with the general population, according to study results published in the Medical Journal of Australia.

In particular, some of the leading causes of death included ischemic heart disease (or damage in the heart’s blood vessels) and cerebrovascular disease (or stroke), according to the study results.

“Cancer control systems should incorporate monitoring of long-term survivorship outcomes including non-cancer-related mortality and managing risk factors for premature death from non-cancer causes,” the study authors wrote.

In this study, researchers analyzed data from 32,646 patients (50% men; mean age at diagnosis, 60 years) from South Australia who were alive five years after receiving their initial diagnosis of cancer. The most common cancer types among these patients included prostate (18.3%), breast (19.2%), gastrointestinal (15.4%) and skin (15.9%). In addition, 4.8% of patients had multiple cancer types.

The goal of the study was to assess cancer-specific mortality and all-cause mortality by cancer type. Patients were followed up until 2016 for a median of 17 years.

During follow-up, 53% of patients died at a mean age of 81 years. Of these deaths, 45% were associated with cancer and 55% were related to non-cancer-related causes. The most common cause of death was ischemic heart disease (15.7%). Other common causes of death included prostate cancer (9.3%), cerebrovascular disease (7.7%) and breast cancer (7.3%).

Researchers also calculated the overall standardized mortality ratio, defined as a ratio of deaths of patients in this study compared with an estimated number of deaths in the general population. The overall standardized mortality ratio was 1.24 after the researchers took into consideration factors such as sex, age and the year of cancer diagnosis.

Study results demonstrated that the number of deaths from cardiovascular disease exceeded that of deaths from cancer-related causes approximately 13 years after patients received their diagnosis of cancer.

“Our findings may partly reflect the high prevalence of and mortality from cardiovascular disease in Australia, but we also found that cardiovascular mortality was higher than in the general population,” the study authors wrote. “Our findings suggest an interaction between cancer or its treatment and cardiovascular risk factors. The interaction may reflect a biological phenomenon (such as the direct toxic effect of anti-cancer treatment on the heart or vascular system), or it may reflect lack of prioritization of cardiovascular disease by patients, or health care focused on treating cancer.”

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
Image of woman with text.
Patients can prepare personal overviews to help care teams connect with them as individuals, explained Michelle Kirschner in an interview with CURE.
Image of woman.
Image of two people.
Image of woman.
Image of kelly.
Image of Doctor.
Anne M. Reb is a nurse practitioner with City of Hope.
Adolescent and Young Adult Cancer Awareness Week sheds light on the financial hardships young cancer survivors face, including debt and limited assistance.
Related Content
Advertisement
Mark Daniels, 83, says CAR T-cell therapy and strong support helped him overcome lymphoma twice.
July 2nd 2025

Veteran Credits CAR T-Cell Therapy With Helping Him Reach Remission

Spencer Feldman
Mark Daniels, 83, says CAR T-cell therapy and strong support helped him overcome lymphoma twice and return to the fitness-focused life he values.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Image of women with text.
June 30th 2025

The Hidden Cost of Cancer: Time Toxicities and Insurance Delays

Ryan Scott
Dr. Alexandra Zaleta discusses how most cancer patients face prior authorization delays, despite 95% being approved, highlighting the need for reform.
Megan Piotrowicz
December 22nd 2022

Childhood Cancer Survivor Pays It Forward at the Same Hospital She Received Treatment

Sailaja Darisipudi Darlene Dobkowski, MA
A childhood cancer survivor now works raising funds for Children’s Hospital of Philadelphia, the same hospital where she received treatment for Ewing sarcoma at 12 years old.
Image of ribbon
June 29th 2025

What Does National Cancer Survivors Month Mean to You?

Ryan Scott
CURE asked cancer survivors, thrivers, advocates, and those whose lives have been touched by cancer: what does National Cancer Survivors Month mean to you?
At age 19, stage 4 blood cancer changed everything, leading to a journey of resilience and quiet hope: © stock.adobe.com.
June 28th 2025

This Wasn't the Plan: When the World Shifted After Cancer

Ajay Shanker Mishra
At age 19, I was a medical student with big dreams — until stage 4 blood cancer changed everything, leading to a journey of resilience and quiet hope.
Related Content
Advertisement
Mark Daniels, 83, says CAR T-cell therapy and strong support helped him overcome lymphoma twice.
July 2nd 2025

Veteran Credits CAR T-Cell Therapy With Helping Him Reach Remission

Spencer Feldman
Mark Daniels, 83, says CAR T-cell therapy and strong support helped him overcome lymphoma twice and return to the fitness-focused life he values.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Image of women with text.
June 30th 2025

The Hidden Cost of Cancer: Time Toxicities and Insurance Delays

Ryan Scott
Dr. Alexandra Zaleta discusses how most cancer patients face prior authorization delays, despite 95% being approved, highlighting the need for reform.
Megan Piotrowicz
December 22nd 2022

Childhood Cancer Survivor Pays It Forward at the Same Hospital She Received Treatment

Sailaja Darisipudi Darlene Dobkowski, MA
A childhood cancer survivor now works raising funds for Children’s Hospital of Philadelphia, the same hospital where she received treatment for Ewing sarcoma at 12 years old.
Image of ribbon
June 29th 2025

What Does National Cancer Survivors Month Mean to You?

Ryan Scott
CURE asked cancer survivors, thrivers, advocates, and those whose lives have been touched by cancer: what does National Cancer Survivors Month mean to you?
At age 19, stage 4 blood cancer changed everything, leading to a journey of resilience and quiet hope: © stock.adobe.com.
June 28th 2025

This Wasn't the Plan: When the World Shifted After Cancer

Ajay Shanker Mishra
At age 19, I was a medical student with big dreams — until stage 4 blood cancer changed everything, leading to a journey of resilience and quiet hope.
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.